According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -A$33.93 M. In 2023 the company made an earning of -A$40.55 M an increase over its 2022 earnings that were of -A$61.96 M.The earnings displayed on this page is the company's Pretax Income.